Huang, R., Wang, X., Yan, H., Tan, X., Ma, Y., Wang, M., . . . Zhang, X. Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: Preclinical evaluation and phase I trial. BMC.
Chicago Style (17th ed.) CitationHuang, Ruihao, et al. Safety and Efficacy of CD33-targeted CAR-NK Cell Therapy for Relapsed/refractory AML: Preclinical Evaluation and Phase I Trial. BMC.
MLA (9th ed.) CitationHuang, Ruihao, et al. Safety and Efficacy of CD33-targeted CAR-NK Cell Therapy for Relapsed/refractory AML: Preclinical Evaluation and Phase I Trial. BMC.
Warning: These citations may not always be 100% accurate.